Delcath Systems Reports Second Quarter 2022 Results and Provides Business Update
- Monday, August 8, 2022, 7:04
- Finance
- Add a comment
NEW YORK, Aug. 8, 2022 /PRNewswire/ — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business highlights and financial results for the second quarter ended June 30, 2022….
About the Author
adminasapcorp has written 41562 stories on this site.